avianinfluenza.org

Research Group Discovers Potential Bird Flu Treatment

Updated: Friday, April 10, 2020 11:26 AM EDT
Avian influenza Articles
Preparing for Human, H5N1 bird flu outbreak
Bird flu symptoms
Can you catch Bird Flu , Avian Influenza from eating poultry?
Confirmed human H5N1 bird flu cases
The origins of Bird Flu
Your cat and Bird flu , avian influenza
Potential bird flu treatment discovery
Bird flu , Avian influenza, new Spanish flu of 1918?
Bird Flu scare and the US bird Embargo
Bird flu , Avian Influenza a non-technical view
Bird flu , Avian flu outbreaks (human to human) in North America
Bird flu , Avian Influenza virus in Smuggled Thai Eagles
Bird flu , Avian Influenza Mutation H5N1 Virus
H5N1 Bird flu , Avian Influenza human vaccine developments
Bird flu , Avian influenza, fact or fiction?
Economic and Social Impacts of Bird Flu , Avian Influenza
Preparing For Pandemic Influenza
Bird Flu , Avian Influenza FAQ
Trial of Experimental Bird Flu , Avian Influenza Vaccine
Bird flu , Avian Influenza infection in Humans
Bird Flu , Avian Influenza explained

Bird Flu Map Links
USGS Interactive Bird flu map
Whooper Swan Tracking Map
Bird flu - US Government

RESEARCH GROUP DISCOVERS POTENTIAL BIRD FLU TREATMENT

SAN DIEGO – (Dec. 17, 2005) The La Jolla Institute for Allergy & Immunology (LIAI) is making significant strides in the battle against the avian “bird” flu, with pre-clinical trials under way on a potential treatment conceived by one of its scientists.  The Institute, a not-for-profit organization whose cutting-edge research focuses on infectious diseases and other immune system disorders, is also developing information for a “universal” flu vaccine, as well as researching a needle-free vaccine that would treat various influenza strains, including the avian flu.  

The Institute, which launched an Emerging Infectious Disease and Biodefense Research Center in 2004, is conducting three major research initiatives to attack the influenza virus -- all of which may be applicable to the avian flu strain, known as the H5N1 virus.  “We understand the devastating potential of an avian flu outbreak as well as the problems caused each year by the more conventional flu strains,” said Mitchell Kronenberg, LIAI President and Scientific Director, noting that 200,000 Americans are hospitalized and 36,000 die each year from the flu.  “Our researchers are working diligently to understand the cellular mechanisms that hold the key to preventing or treating influenza,” he said. “We are particularly excited that our research shows promise against the avian flu, as that may be the most urgent health issue now facing the world.”  

A potential treatment for the avian flu involving human flu-fighting antibodies was conceived by LIAI scientist Hilde Cheroutre, Ph.D., and initiated through a collaborative effort of LIAI and Gemini Science, a biopharmaceutical research and development company and wholly-owned U.S. subsidiary of Kirin Brewery Co., Ltd. of Japan.  Gemini moved forward in 2000 with laboratory testing on the antibodies, which have produced preliminary data showing positive results against numerous flu strains, including the H5N1 avian flu.  

Cheroutre’s concept focused on M2, a protein common to all influenza A viruses, including avian flu strains.  Her insight was to suggest using a portion of the M2 protein to immunize Transchromosomic mice™, which are mice genetically-engineered to produce human antibodies.  The TC Mouse™ Technology, developed by Kirin’s Pharmaceutical Division, allowed researchers to obtain influenza M2-specific human antibodies.  

In conducting the research, Gemini scientists used synthetically created pieces of the H5NI avian flu virus, along with a number of other synthesized virus pieces, to analyze the effectiveness of the human anti-M2 antibodies, which had been created from theTranschromosomic mice™.  “In laboratory (in vitro) testing, they found that the anti-M2 antibodies bound to several different influenza strains, including the avian flu virus (H5N1),” Cheroutre said.  “This reactivity means that if used in vivo (in a living organism) the infected cells would be recognized by the antibody and destroyed by the immune system.”  The study also  found that a relatively low dose of the antibodies was needed to fight the various flu strains.   

While most of the work was done on virus pieces to avoid the risk of using actual viruses, Gemini also tested the M2 antibodies on mice infected with a potentially lethal influenza strain, with similarities to the avian flu virus.  “They found that those mice which received the human M2 antibody were protected, while those mice that did not get the M2 antibody would die,” Cheroutre said.   

Based upon the lab and mice testing, Gemini Science is now initiating pre-clinical studies required for the commencement of human clinical testing of the anti-M2 antibody, said Shinichiro Kato, Ph.D., Gemini’s Chief Scientific Officer.  Gemini, which is testing the antibody both as a treatment and preventative measure against flu, has expedited the research due to the recent cases of avian flu.  Gemini is currently in discussions with the Centers for Disease Control (CDC) about establishing a Cooperative Research and Development Agreement to jointly conduct further research.  Gemini’s findings will be presented today at the 45th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), which runs through Monday in Washington, D.C.  

LIAI scientists are also engaged in other promising flu-related research, including work by scientist David Lo, M.D., Ph.D.   Together with Neurome, Inc. in San Diego, Lo recently received a $3.9 million Bill and Melinda Gates Foundation Grand Challenges in Global Health grant to work on a mucosal flu vaccine that could be given orally or nasally.  This needle-free vaccine delivery system would enable vaccines to be administered in any field setting without the need for complex equipment or specialized training.  This would be particularly helpful for improving health in third world countries, which is the focus of the Gates grant.  Along with a novel delivery system, if successful Lo’s research would produce the world’s first targeted mucosal flu vaccine, which would bind to specific receptors in mucosal surfaces such as airways and intestine.  It is believed that such a vaccine would produce more rapid, potent and longer lasting flu protection than today’s vaccines, because it would attack the virus in the mucosal linings where it enters the body.  Lo said the vaccine would be designed to fight numerous flu strains, including the H5N1 avian flu.  

LIAI’s other major area of flu research involves studies that could lead to the development of a “universal” flu vaccine, meaning one that would protect against a broad cross section of flu viruses.   

LIAI scientist Dr. Alessandro Sette, Ph.D., a renowned vaccine expert, is using powerful biomedical research tools to measure the immune response of people who have previously had the flu.  His work involves comparing the various immune system reactions of test subjects against the genetic sequence of the vaccine virus.  

“We are interested in seeing whether there are different components or pieces of the flu virus that are recognized by the immune system,” he said, explaining this would mean the immune system had seen those pieces previously in earlier flu exposures. “Specifically, we’re looking to see if there are proteins or genes that are common to many flu viruses that are targets of the immune response.  If so, it may be possible to develop a vaccine with greater cross protection because it would recognize elements common to all flu viruses.”  

#####

About LIAI, Founded in 1988, the La Jolla Institute for Allergy and Immunology is a nonprofit medical research center dedicated to increasing knowledge and improving human health through studies of the immune system. Scientists at the institute carry out research searching for cures for cancer, allergy and asthma, infectious diseases, and autoimmune diseases such as diabetes, inflammatory bowel disease and arthritis. LIAI's research staff includes more than 100 Ph.Ds.

Source: La Jolla Institute for Allergy & Immunology

Bird flu found in South Carolina turkey flock - Farm and Dairy
10 Apr 2020 at 11:05am
Bird flu found in South Carolina turkey flock - Farm and Dairy
10 Apr 2020 at 11:05am
First US bird flu find since 2017 may not cause as many trade disruptions - I...
10 Apr 2020 at 8:39am
First US bird flu find since 2017 may not cause as many trade disruptions - I...
10 Apr 2020 at 8:39am
Bird flu reported in commercial turkey flock in South Carolina - WWAY NewsCha...
10 Apr 2020 at 6:18am
Bird flu reported in commercial turkey flock in South Carolina - WWAY NewsCha...
10 Apr 2020 at 6:18am
Global Bird Flu Treatment Market (impact of COVID-19) 2020-2026 Pfizer, Cipla...
10 Apr 2020 at 2:15am
Global Bird Flu Treatment Market (impact of COVID-19) 2020-2026 Pfizer, Cipla...
10 Apr 2020 at 2:15am
US confirms first case of H7N3 bird flu since 2017 - The Jerusalem Post
10 Apr 2020 at 1:58am
US confirms first case of H7N3 bird flu since 2017 - The Jerusalem Post
10 Apr 2020 at 1:58am
U.S. detects its first case of virulent bird flu in commercial poultry since ...
9 Apr 2020 at 1:30pm
U.S. detects its first case of virulent bird flu in commercial poultry since ...
9 Apr 2020 at 1:30pm
How Did ?Spanish Flu? Get Its Name? - Snopes.com
9 Apr 2020 at 12:59pm
How Did ?Spanish Flu? Get Its Name? - Snopes.com
9 Apr 2020 at 12:59pm
Researchers assess bird flu virus subtypes in China - Science Daily
8 Apr 2020 at 6:36am
Researchers assess bird flu virus subtypes in China - Science Daily
8 Apr 2020 at 6:36am
How Australia's 2020 Summit in 2008 focused on mosquito illnesses, bird flu i...
7 Apr 2020 at 12:31am
How Australia's 2020 Summit in 2008 focused on mosquito illnesses, bird flu i...
7 Apr 2020 at 12:31am
State not affected by Bird Flu: Goa Poultry Assn - Oherald
3 Apr 2020 at 4:57pm
State not affected by Bird Flu: Goa Poultry Assn - Oherald
3 Apr 2020 at 4:57pm
Ranchi spooked by bird flu fears amid Covid scare - Times of India
2 Apr 2020 at 4:33pm
Ranchi spooked by bird flu fears amid Covid scare - Times of India
2 Apr 2020 at 4:33pm
Indonesian COVID-19 deaths surpass, within weeks, 17 years of bird flu fatali...
2 Apr 2020 at 12:00am
Indonesian COVID-19 deaths surpass, within weeks, 17 years of bird flu fatali...
2 Apr 2020 at 12:00am
Coronavirus, Swine Flu, SARS: Major Diseases Linked to Eating Animals - PETA UK
25 Mar 2020 at 4:01pm
Coronavirus, Swine Flu, SARS: Major Diseases Linked to Eating Animals - PETA UK
25 Mar 2020 at 4:01pm
Bihar?s double whammy: Bird flu comes knocking in times of coronavirus - Indi...
24 Mar 2020 at 7:34am
Bihar?s double whammy: Bird flu comes knocking in times of coronavirus - Indi...
24 Mar 2020 at 7:34am
What The 1918 Flu Pandemic Teaches Us About The Coronavirus Outbreak - WBUR
24 Mar 2020 at 12:00am
What The 1918 Flu Pandemic Teaches Us About The Coronavirus Outbreak - WBUR
24 Mar 2020 at 12:00am
16 cases of bird flu confirmed in UK so far this year - FarmingUK
24 Mar 2020 at 12:00am
16 cases of bird flu confirmed in UK so far this year - FarmingUK
24 Mar 2020 at 12:00am
Germany confirms another case of H5N8 bird flu on a farm - Reuters
23 Mar 2020 at 1:49am
Germany confirms another case of H5N8 bird flu on a farm - Reuters
23 Mar 2020 at 1:49am
Authorities on alert after Bird Flu killed birds at Birsa Zoo - Daily Pioneer
22 Mar 2020 at 12:00am
Authorities on alert after Bird Flu killed birds at Birsa Zoo - Daily Pioneer
22 Mar 2020 at 12:00am
China removes threat of total ban on U.S. poultry if bird flu is found: indus...
20 Mar 2020 at 3:43pm
China removes threat of total ban on U.S. poultry if bird flu is found: indus...
20 Mar 2020 at 3:43pm
How coronavirus, bird flu and rumours to stay off non-veg hit poultry industr...
20 Mar 2020 at 12:00am
How coronavirus, bird flu and rumours to stay off non-veg hit poultry industr...
20 Mar 2020 at 12:00am